(Q54381914)

29 May 2018

title

Resistance to Recombinant Interferon Alfa-2a in Hairy-Cell Leukemia Associated with Neutralizing Anti-Interferon Antibodies (English)

1 reference

https://api.crossref.org/works/10.1056/NEJM198806023182201

2 January 2023

1 reference

1 reference

8

Longo DL

2 references

29 May 2018

PubMed ID

3367950

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A3367950

2 January 2023

author name string

Steis RG

1

1 reference

29 May 2018

Smith JW 2nd

2

1 reference

29 May 2018

Urba WJ

3

1 reference

29 May 2018

Clark JW

4

1 reference

29 May 2018

Itri LM

5

1 reference

29 May 2018

Evans LM

6

1 reference

29 May 2018

Schoenberger C

7

1 reference

29 May 2018

language of work or name

English

0 references

publication date

1 June 1988

1 reference

29 May 2018

2 June 1988

1 reference

National Center for Biotechnology Information

PubMed ID

3367950

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=3367950

full work available at URL

2 January 2023

http://www.nejm.org/doi/pdf/10.1056/NEJM198806023182201

1 reference

https://api.crossref.org/works/10.1056/NEJM198806023182201

The New England Journal of Medicine

2 January 2023

published in

1 reference

29 May 2018

volume

318

1 reference

29 May 2018

issue

22

1 reference

29 May 2018

page(s)

1409-1413

1 reference

29 May 2018

Alpha interferon for induction of remission in hairy-cell leukemia

cites work

1

1 reference

https://api.crossref.org/works/10.1056/NEJM198806023182201

Treatment of hairy cell leukemia with recombinant alpha 2 interferon

2 January 2023

2

1 reference

https://api.crossref.org/works/10.1056/NEJM198806023182201

2 January 2023

Cancer Treatment Reports

4

69

791

Thompson

1985

1 reference

https://api.crossref.org/works/10.1056/NEJM198806023182201

Recombinant alpha-2 interferon for treatment of hairy cell leukemia without prior splenectomy.

2 January 2023

5

1 reference

https://api.crossref.org/works/10.1056/NEJM198806023182201

Treatment with low dose human recombinant interferon-alpha-2-ARG induces complete remission in patients with hairy cell leukemia.

2 January 2023

6

1 reference

https://api.crossref.org/works/10.1056/NEJM198806023182201

Successful use of interferon alfa-n1 in the treatment of hairy cell leukemia

2 January 2023

7

1 reference

https://api.crossref.org/works/10.1056/NEJM198806023182201

Primary treatment of hairy cell leukemia: should IFN-therapy replace splenectomy?

2 January 2023

8

1 reference

https://api.crossref.org/works/10.1056/NEJM198806023182201

Interferon-alpha-2C in the treatment of advanced hairy cell leukaemia. Results of a phase II trial

2 January 2023

9

1 reference

https://api.crossref.org/works/10.1056/NEJM198806023182201

Recombinant leukocyte A interferon therapy for advanced hairy cell leukemia. Therapeutic and immunologic results

2 January 2023

10

1 reference

https://api.crossref.org/works/10.1056/NEJM198806023182201

Antitumor activity of recombinant-derived interferon alpha in metastatic renal cell carcinoma

2 January 2023

12

1 reference

https://api.crossref.org/works/10.1056/NEJM198806023182201

Clinical trial of recombinant leukocyte A interferon as initial therapy for favorable histology non-Hodgkin's lymphomas and chronic lymphocytic leukemia. An Eastern Cooperative Oncology Group pilot study

2 January 2023

13

1 reference

https://api.crossref.org/works/10.1056/NEJM198806023182201

Treatment of advanced non-Hodgkin's lymphoma with recombinant leukocyte A interferon

2 January 2023

14

1 reference

https://api.crossref.org/works/10.1056/NEJM198806023182201

Clinical significance of anti-IFN-alpha antibody titres during interferon therapy

2 January 2023

15

1 reference

https://api.crossref.org/works/10.1056/NEJM198806023182201

Incidence and clinical significance of neutralizing antibodies in patients receiving recombinant interferon alfa-2a by intramuscular injection

2 January 2023

16

1 reference

https://api.crossref.org/works/10.1056/NEJM198806023182201

2 January 2023

Identifiers

1 reference

29 May 2018

PubMed ID

3367950

1 reference

29 May 2018